Compassionate Use of Lumacaftor/Ivacaftor in Cystic Fibrosis: Spanish Experience

Diab-Caceres, L; Giron-Moreno, RM; Pastor-Sanz, MT; Quintana-Gallego, E; Delgado-Pecellin, I; Blanco-Aparicio, M; Maiz, L; Garcia-Clemente, MM; Luna-Paredes, C; Mondejar-Lopez, P; Ruiz-de-Valbuena, M; Fernandez, O; Barrio, M; Gonzalez, M; Lopez-Neyra

Diab-Caceres, L (reprint author), Hosp La Princesa, Respirol, Madrid, Spain.

ARCHIVOS DE BRONCONEUMOLOGIA, 2018; 54 (12): 614

Abstract

Background: The most common cystic fibrosis (CF)-causing mutation is deltaF508 (F508del), which is present in 28% of CF Spanish patients. While the li......

Full Text Link